Natural History: HCV symptoms, disease progression and management..



o   1612. Relationship of Iron [Fe] and HFE genetic variations to progression and outcomes of advanced chronic hepatitis C in the HALT-C Trial.

o   1613. Aging of Hepatitis C Infected Persons in the United States: A Multiple Cohort Model of HCV Prevalence and Disease Progression. (updated Nov 5, 2009)

o   1617. Incidence of end-stage liver disease and death among 585 HIV/HCV coinfected adults according to baseline fibrosis stage. (updated Nov 5, 2009)

o   1620. Validation of a panel of genetic markers (CRS7) in predicting cirrhosis, fibrosis progression (FP) and clinical outcomes in patients with chronic hepatitis C (CHC) in the HALT-C trial.

o   1622. Insulin Resistance and Hepatic Steatosis are Both Independently Associated with Advanced Hepatic Fibrosis in Chronic Hepatitis C Infection: Analysis of the ACHIEVE 1 and ACHIEVE 2/3 Cohorts

o   1625. Serum fibrosis markers are associated with clinical outcomes and histological progression in patients with chronic hepatitis C (CHC) and advanced fibrosis.

o   1626. Chronic Hepatitis C Infection is Associated with Lower Rates of Hospitalization for Coronary Heart Disease.

o   1627. Hepatic Impairment Measured by Quantitative Tests of Liver Function (QLFTs) Predicts Clinical Outcome in Patients with Advanced Fibrosis: Results from the Hepatitis C Antiviral Long-Term Treatment against Cirrhosis (HALT-C) Trial.

o   1650. Long-term evaluation of fibrosis by Transient Elastography in patients clearing HCV on antiviral therapy.

o   1655. Quantitative HCV core antigen and HCV-RNA kinetics in HCV infected patients over a period of up to 8 years.

o   1656. The Extent of Liver Fibrosis Measured Using Transient Elastometry Predicts Mortality in HIV Patients with Liver Cirrhosis.

o   1657. Amino acid substitutions in the hepatitis C virus core region were induced by aging and severe hepatic fibrosis.

o   1658. Semen Characteristics In Hepatitis C Virus (HCV) Infected Patients. Relationship Between Semen Characteristics And Assisted Reproduction Technologies (ART) Practice. (updated Nov 5, 2009)

o   1659. Excessive alcohol intake drastically impacts transplant-free survival: a longitudinal study in HCV cirrhotic patients (updated Nov 9, 2009)

o   1663. Prediction of HCV-related mortality in Belgium using a mathematical modeling approach: impact of current treatment practice and different scenarios improving screening, access to treatment and treatment efficacy.


o   Acute HCV

  1619. Natural clearance of hepatitis C virus (HCV) RNA in chronic HCV carriers: A long-term cohort study in an endemic area of HCV infection in Japan.

  1662. Early spontaneous resolution of acute hepatitis C depends on the HCV genotypes and the levels of HCV RNA.


o   Biopsy

  1629. Paired Biopsies Illustrate Racial Differences in Fibrosis Progression in HCV Patients.

  1630. Age, Insulin Resistance and Steatosis are Independent Risk Factors for Fibrosis Progression in Untreated Patients with Mild Chronic Hepatitis C: A Prospective Study with Repeat Biopsies. (updated Nov 13, 2009)

  1639. Hepatic fibrosis regression in the setting of persistent viremia in chronic hepatitis C: a dual biopsy study.

  1654. Diagnosis of occult HCV infection without performing a liver biopsy.


o   Quality of Life

  1644. Resilience affects the quality of life in patients with chronic hepatitis C. (updated Nov 5, 2009)

  1645. Self-reported cognitive symptoms are commonly associated with underlying neurocognitive impairment in hepatitis C infected patients referred for antiviral treatment. (updated Nov 5, 2009)


o   Women

o   1615. Early loss of exposure to Estrogens is critical in determining entity of fibrosis and response to IFN in women with hepatitis C.

o   1631. Hepatitis C and menopause: interplay of age, gender, HCV replication and activity in progression and consequence for therapy. (updated Nov 13, 2009)